Powder: -20°C for 3 years
In solvent: -80°C for 6 months
Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | 81.00 | |
100 mg | In stock | 188.00 | |
1 mL * 10 mM (in DMSO) | In stock | 50.00 |
Description | Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. |
Targets&IC50 | aromatic-L-amino-acid decarboxylase |
Synonyms | (S)-(-)-Carbidopa , Lodosyn , Lodosyn , (S)-(-)-Carbidopa |
Purity | 98.00% |
Molecular Weight | 226.23 |
Formula | C10H14N2O4 |
CAS No. | 28860-95-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 6 months
DMSO: 4.5 mg/mL (20 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.